Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults

被引:28
作者
Wilson, AM [1 ]
Clark, DJ [1 ]
Devlin, MM [1 ]
McFarlane, LC [1 ]
Lipworth, BJ [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Resp Med, Dundee DD1 9SY, Scotland
关键词
asthma; fluticasone propionate; budesonide;
D O I
10.1007/s002280050385
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: The aim of this study was to evaluate the steady-state effects of once-daily inhaled fluticasone propionate (FP) and budesonide (BUD) on adrenocortical activity in asthmatic patients. thods: Ten asthmatic patients with a mean age of 31.2 years, a mean forced expiratory volume in 1 s (FEV1) of 91% predicted and a forced mid-expiratory flow (FEF25-75) of 62.3% predicted were studied in a single-blind randomised crossover design comparing placebo (PL), FP (375 mu g per day and 750 mu g per day) and BUD (400 mu g per day and 800 mu g per day) all given once daily for 4 days at each dose via a pressurised metered dose inhaler (pMDI) at 0800 hours. After 4 days of treatment, plasma cortisol was measured at 0800 hours (24 h after the last dose) and a 10-h overnight urine collection was taken, 14 h after the last dose (2200-0800 hours) for analysis of cortisol and creatinine excretion. Results: Plasma cortisol levels (nmol.l(-1) as geometric mean) at 0800 hours demonstrated a significant difference between the highest doses of FP and BUD (424.1 vs 510.3 nmol.l(-1) respectively) but not between the low doses (506.8 vs 514.9 nmol.l(-1) PL 532.2 nmol.l(-1)). For the highest dose FP (750 mu g) this equated to 20% suppression of 0800 hours plasma cortisol. Likewise, for overnight urinary cortisol output (nmol.10 h(-1), as geometric mean), there was a significant difference at the high doses of FP and BUD (25.5 vs 38.2 nmol 10 h(-1)), but not at the low doses 31.3 vs 34.8 nmole 10 h(-1) PL 32.0 nmol.10 h(-1). For the overnight urinary cortisol/creatinine ratio (nmol.mmol(-1), as geometric mean) there was a similar trend; 4.5 vs 6.1 nmol.mmol(-1) for high dose and 5.6 vs 6.3 nmol.mmol(-1) for low dose; PL5.9 nmol mmol(-1). Conclusion: Repeated doses of FP 750 mu g once daily caused greater adrenal suppression than BUD 800 mu g once daily, when comparing effects on plasma cortisol levels at 0800 hours, 24 h after the last dose, as well as effects on overnight urinary cortisol output. Neither FP 375 mu g once daily nor BUD 400 mu g once daily produced detectable adrenal suppression.
引用
收藏
页码:317 / 320
页数:4
相关论文
共 17 条
[1]  
AGERTOFT L, 1996, AM J RESP CRIT CARE, V153, pA408
[2]   Assessment of the relative systemic potency of inhaled fluticasone and budesonide [J].
Boorsma, M ;
Andersson, N ;
Larsson, P ;
Ullman, A .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (07) :1427-1432
[3]   LOW-DOSE ADRENOCORTICOTROPIN TEST REVEALS IMPAIRED ADRENAL-FUNCTION IN PATIENTS TAKING INHALED CORTICOSTEROIDS [J].
BROIDE, J ;
SOFERMAN, R ;
KIVITY, S ;
GOLANDER, A ;
DICKSTEIN, G ;
SPIRER, Z ;
WEISMAN, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04) :1243-1246
[4]   Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients [J].
Clark, DJ ;
Lipworth, BJ .
THORAX, 1997, 52 (01) :55-58
[5]   Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients [J].
Clark, DJ ;
Grove, A ;
Cargill, RI ;
Lipworth, BJ .
THORAX, 1996, 51 (03) :262-266
[6]   Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children [J].
Clark, DJ ;
Clark, RA ;
Lipworth, BJ .
THORAX, 1996, 51 (09) :941-943
[7]  
ENGLISH AF, 1994, AM J RESP CRIT CAR S, V149, pA212
[8]   BINDING-KINETICS OF FLUTICASONE PROPIONATE TO THE HUMAN GLUCOCORTICOID RECEPTOR [J].
HOGGER, P ;
ROHDEWALD, P .
STEROIDS, 1994, 59 (10) :597-602
[9]   EFFECTS OF INTRANASAL GLUCOCORTICOIDS ON ENDOGENOUS GLUCOCORTICOID PERIPHERAL AND CENTRAL FUNCTION [J].
KNUTSSON, U ;
STIERNA, P ;
MARCUS, C ;
CARLSTEDTDUKE, J ;
CARLSTROM, K ;
BRONNEGARD, M .
JOURNAL OF ENDOCRINOLOGY, 1995, 144 (02) :301-310
[10]   Airway and systemic effects of inhaled corticosteroids in asthma: Dose response relationship [J].
Lipworth, BJ .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1996, 9 (01) :19-27